Skip to search formSkip to main contentSkip to account menu

Sandimmun Neoral

Known as: CyA NOF, CyA-NOF, neoral sandimmun 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cyclosporine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Development of cyclosporin A-loaded hyaluronic microsphere with enhanced oral bioavailability.
2002
2002
Pharmacokinetic and pharmacodynamic evaluation of cyclosporin A O/W-emulsion and microsphere formulations in rabbits.
1999
1999
A limited sampling strategy for the estimation of Neoral AUCs in pediatric patients
Abstract The improved pharmacokinetics of Neoral allows the development of an accurate estimate of the full area under the… 
1999
1999
The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate-cure with ketoconazole and allopurinol.
Introduction A 66-year-old white Caucasian man was admitted to our hospital 21 weeks after renal transplantation for the… 
1997
1997
Monitoring New Immunosuppressive Agents Are the Methods Adequate?
There is an expanding range of immunosuppressive drugs and it is common practice for measurements of these drugs to be made as a… 
Review
1995
Review
1995
Sandimmun neoral pharmacokinetics: impact of the new oral formulation.
1992
1992
Acute lichen planus treated by Sandimmun (ciclosporin)
1991
1991
Safety and tolerability of cyclosporin A (Sandimmun®) in idiopathic nephrotic syndrome
Highly Cited
1985
Highly Cited
1985
Purification and characterization of a neurite outgrowth factor from chicken gizzard smooth muscle.
Highly Cited
1978
Highly Cited
1978
Free radicals and carcinogenesis. Some properties of the nitroxyl free radicals produced by covalent binding of 2-nitrosofluorene to unsaturated lipids of membranes.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)